Chemcaps Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.35 Cr
as on 16-11-2024
- Company Age 44 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.20 Cr
as on 16-11-2024
- Revenue -68.25%
(FY 2023)
- Profit -13.38%
(FY 2023)
- Ebitda -4.80%
(FY 2023)
- Net Worth -19.45%
(FY 2023)
- Total Assets -2.37%
(FY 2023)
About Chemcaps
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.35 Cr.
The company has closed loans amounting to ₹2.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Arun Mittal, Preeti Saxena, and Prem Goel serve as directors at the Company.
- CIN/LLPIN
U51397DL1980PLC091361
- Company No.
091361
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Jun 1980
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chemcaps Limited offer?
Chemcaps Limited offers a wide range of products and services, including Pharma Raw Material, Empty Hard Gelatin Capsules, Pharma Ingredients & Raw Materials.
Who are the key members and board of directors at Chemcaps?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Mittal  | Director | 18-Jun-1983 | Current |
| Preeti Saxena | Director | 28-Apr-2023 | Current |
| Prem Goel | Director | 18-Jun-1983 | Current |
Financial Performance and Corporate Structure Insights of Chemcaps.
Chemcaps Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.25% decrease. The company also saw a substantial fall in profitability, with a 13.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemcaps?
In 2023, Chemcaps had a promoter holding of 69.45% and a public holding of 30.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 22 Mar 2006 | ₹2.20 Cr | Satisfied |
Oriental Bank Of Commerce Creation Date: 25 Oct 1996 | - | Satisfied |
Oriental Bank Of Commerce Creation Date: 25 Oct 1996 | - | Satisfied |
How Many Employees Work at Chemcaps?
Unlock and access historical data on people associated with Chemcaps, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemcaps, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemcaps's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
